PSNC Briefing 016/19: EPS Controlled Drugs (CD) FAQs
PSNC Briefing 016/19: EPS Controlled Drugs (CD) FAQs
This briefing factsheet for pharmacy contractors sets outs frequently asked EPS CD questions and responses.
PSNC Briefing 016/19: EPS Controlled Drugs (CD) FAQs factsheet (updated 2021)
If you have any queries on this PSNC Briefing, or you require more information, please contact Daniel Ah-Thion, Community Pharmacy IT Lead or Layla Rahman, Regulations Officer.
To browse other PSNC briefings on Contract and IT, click here.
Return to the Pharmacy IT hub or IT a-z index
